Complexo Hospitalario Universitario de Santiago
Centro de atención
University of Pisa
Pisa, ItaliaPublicacións en colaboración con investigadores/as de University of Pisa (18)
2023
-
Direct long-acting antibodies: updating the language of RSV prevention to reflect the evolution of mAbs
Journal of Preventive Medicine and Hygiene, Vol. 64, Núm. 4, pp. E377-E381
2022
-
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103
-
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved
Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058
-
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Nature, Vol. 604, Núm. 7906, pp. 502-508
2021
-
Empagliflozin in heart failure with a preserved ejection fraction
New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461
2020
-
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial
European Journal of Heart Failure, Vol. 22, Núm. 12, pp. 2383-2392
-
Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” (Pancreatology (2018) 18(8) (847–854), (S1424390318306938), (10.1016/j.pan.2018.09.016))
Pancreatology
2019
-
Development of scores assessing the refluxogenic potential of diet of patients with laryngopharyngeal reflux
European Archives of Oto-Rhino-Laryngology, Vol. 276, Núm. 12, pp. 3389-3404
-
Treatment of laryngopharyngeal reflux disease: A systematic review
World Journal of Clinical Cases, Vol. 7, Núm. 19, pp. 2995-3011
2018
-
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529
-
Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis
Pancreatology, Vol. 18, Núm. 8, pp. 847-854
2011
-
Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice
Autoimmunity Reviews, Vol. 10, Núm. 7, pp. 383-388
2010
-
Assessment of multiple organ systems in systemic lupus erythematosus: What will the new guidelines mean?
International Journal of Clinical Rheumatology, Vol. 5, Núm. 3, pp. 291-297
-
European league against rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
Annals of the Rheumatic Diseases, Vol. 69, Núm. 7, pp. 1269-1274
2009
-
Moors and Saracens in Europe: Estimating the medieval North African male legacy in southern Europe
European Journal of Human Genetics, Vol. 17, Núm. 6, pp. 848-852
-
Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress
Carcinogenesis, Vol. 30, Núm. 8, pp. 1288-1297